Obesity, Overweight Clinical Trials

79 recruitingLast updated: June 17, 2026

There are 79 actively recruiting obesity, overweight clinical trials across 29 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4, Early Phase 1, Phase 3. Top locations include Clevland, Ohio, United States, Nanjing, Jiangsu, China, Baton Rouge, Louisiana, United States. Updated daily from ClinicalTrials.gov.


Obesity, Overweight Trials at a Glance

79 actively recruiting trials for obesity, overweight are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 50 trials, with the heaviest enrollment activity in Clevland, Nanjing, and Baton Rouge. Lead sponsors running obesity, overweight studies include Gan & Lee Pharmaceuticals., Ian J. Neeland, MD, and The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School.

Browse obesity, overweight trials by phase

Treatments under study

About Obesity, Overweight Clinical Trials

Looking for clinical trials for Obesity, Overweight? There are currently 79 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Obesity, Overweight trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Obesity, Overweight clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 79 trials

Recruiting

Genetic, Microbiological and Behavioral Factors in Obesity

ObesityObesity, OverweightGenetics
Jan Kochanowski University200 enrolled2 locationsNCT07650149
Recruiting
Not Applicable

DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

Obesity, OverweightAsthma (Diagnosis)Type 1 Diabetes+3 more
Adhera Health, Inc.280 enrolled1 locationNCT07638345
Recruiting
Phase 1

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Obesity, Overweight
Corxel Pharmaceuticals90 enrolled2 locationsNCT07652047
Recruiting
Not Applicable

Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer

Obesity, Overweight
University of South Carolina300 enrolled1 locationNCT07583459
Recruiting

Real-World Case Registry Study on Obesity

Obesity, OverweightObesity (Disorder)
Hubei Hospital of Traditional Chinese Medicine10,000 enrolled1 locationNCT07448090
Recruiting
Not Applicable

Long-term Adaptations of Skeletal Muscle After Hybrid Training

Obesity, Overweight
University of Thessaly30 enrolled1 locationNCT07341711
Recruiting
Not Applicable

Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy

Obesity, OverweightDehydrationType 2 Diabetes+2 more
State University of New York at Buffalo30 enrolled1 locationNCT07641361
Recruiting

Eating Behaviour Before, During, and After Obesity Medication

Obesity, OverweightObesity Type 2 Diabetes Mellitus
University College Dublin30 enrolled1 locationNCT07636395
Recruiting
Not Applicable

Ultra-processed Food Consumption and Health Pilot Study

Obesity, Overweight
Pennington Biomedical Research Center6 enrolled1 locationNCT07318064
Recruiting
Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention

Obesity, Overweight
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School24 enrolled1 locationNCT07630597
Recruiting
Not Applicable

Support Your Heart, Phase 1

Diet, HealthySleepPhysical Activity+3 more
George Washington University20 enrolled1 locationNCT07623733
Recruiting
Not Applicable

Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists

Obesity, Overweight
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School24 enrolled1 locationNCT07619989
Recruiting
Not Applicable

Exercise Training and Vitamin D Metabolism

Vitamin DObesity, Overweight
University of Thessaly30 enrolled1 locationNCT07300332
Recruiting
Not Applicable

Sevoflurane vs Propofol Anesthesia in Obese Patients Undergoing Lumbar Surgery

Obesity, OverweightLumbar Spine Surgery
Ataturk University70 enrolled1 locationNCT07611240
Recruiting
Not Applicable

Supplementation With Sirtuin Activators in Women With Increased Body Weight

Obesity, Overweight
Poznan University of Life Sciences120 enrolled1 locationNCT07245979
Recruiting
Not Applicable

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

Obesity, OverweightType 2 Diabetes (T2DM)Obesity (Disorder)
GT Metabolic Solutions, Inc.20 enrolled1 locationNCT07317115
Recruiting
Not Applicable

PREdiabetes GLycemic Impact and Data Evaluation

Insulin ResistanceObesity, OverweightPre-diabetic
Nazarii Kobyliak80 enrolled2 locationsNCT07599072
Recruiting

Predicting Weight Loss After Pharmacological or Surgical Treatment in Patients With Obesity

Obesity, Overweight
Université Catholique de Louvain100 enrolled1 locationNCT07402031
Recruiting

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

Obesity, OverweightChronic Kidney Disease in Type 2 Diabetes
University of Alberta52 enrolled1 locationNCT07187830
Recruiting
Not Applicable

Testing a Tailored Approach to Long-Term Weight Loss Success

Weight LossObesity, OverweightWeight Regain
University of Utah30 enrolled1 locationNCT07577765